Platinum(II) Complexes with Constructive and Destructive Interaction of Diphosphane and Binaphthol Ligands.

Angew Chem Int Ed Engl

Department of Chemistry, CB#3290, University of North Carolina, Chapel Hill, NC 27599-3290 (USA), Fax: (+1) 919-962-6341.

Published: June 1998

Eight molecules with different conformations are present in the unit cell of the Pt complex 1, which contains a mismatched arrangement of the chiral ligands Chiraphos and Binol (i.e., (S,S)-Chiraphos prefers the δ conformation, whereas (R)-Binol tends to induce the λ conformation in the diphosphane). The observed flexibility of these bidentate ligands should not be disregarded in stereochemical models for explaining the selectivity in asymmetric catalysis.

Download full-text PDF

Source
http://dx.doi.org/10.1002/(SICI)1521-3773(19980619)37:11<1579::AID-ANIE1579>3.0.CO;2-ADOI Listing

Publication Analysis

Top Keywords

platinumii complexes
4
complexes constructive
4
constructive destructive
4
destructive interaction
4
interaction diphosphane
4
diphosphane binaphthol
4
binaphthol ligands
4
ligands molecules
4
molecules conformations
4
conformations unit
4

Similar Publications

The discovery of cisplatin (cisPt) as an effective anticancer agent was a milestone in the health industry. Despite its success, undesired side effects and acquired resistance still limit the therapeutic usefulness of cisPt. Intrastrand adduct formation at consecutive purines and structural modifications of DNA caused by platinum(II) complexes are important factors for antitumor efficacy.

View Article and Find Full Text PDF

Transition metal complexes are well-known for their efficient light emission and are promising for applications ranging from bioimaging to light-emitting diodes. In solution, interactions between the metal centers of two complexes become possible and drastically change the photophysical properties. For real-world devices, solid-state materials consisting of these molecules are preferable.

View Article and Find Full Text PDF

Recent advances in ruthenium (III) complex-loaded nanomaterial for enhanced cancer therapy efficacy.

Drug Dev Ind Pharm

January 2025

Guangxi Key Laboratory of Drug Discovery and Optimization, School of Pharmacy, Guilin Medical University, Guilin, China.

Objective: Amid the escalating global cancer incidence, the development of effective and safe anticancer drugs is a critical priority in medical research. Addressing the clinical shortcomings of ruthenium-based anticancer drugs are currently a prominent focus of research.

Significance And Methods: Since the pioneering work with platinum derivatives, significant progress has been made in the fundamental studies of metal complexes for the treatment of a wide range of cancers, and there has been a growing interest in their properties and biomedical applications.

View Article and Find Full Text PDF

Carbazolylpyridine ()-based tetradentate platinum(II) complexes containing fused 6/5/6 metallocycles.

Dalton Trans

January 2025

College of Chemical Engineering, State Key Laboratory Breeding Base of Green-Chemical Synthesis Technology, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, P. R. China.

A series of carbazolylpyridine ()-based 6/5/6 Pt(II) complexes featuring tetradentate ligands with nitrogen or oxygen atoms as bridging groups was designed and synthesized, and the bridging nitrogen atoms were derived from acridinyl (Ac), azaaceridine (AAc) and carbazole (Cz). Systematic experimental and theoretical studies reveal that the ligand structures have a significant effect on the electrochemical, photophysical and excited state properties of these complexes. Their oxidation processes mainly occur on the carbazole-Pt moieties, whereas the reduction processes typically occur on the electron-deficient pyridine (Py) moieties.

View Article and Find Full Text PDF

Correction for 'A novel platinum(II) complex with a berberine derivative as a potential antitumor agent targeting G-quadruplex DNA' by Shu-Lin Zhang , , 2025, https://doi.org/10.1039/d4ob01705f.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!